Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Aug;12(8):1223-30.
doi: 10.3201/eid1708.060017.

Macrolide resistance in adults with bacteremic pneumococcal pneumonia

Joshua P Metlay  1 , Neil O Fishman, Marshall M Joffe, Michael J Kallan, Jesse L Chittams, Paul H Edelstein
Affiliations

Macrolide resistance in adults with bacteremic pneumococcal pneumonia

Joshua P Metlay et al. Emerg Infect Dis. 2006 Aug.

Abstract

We conducted a case-control study of adults with bacteremic pneumococcal pneumonia to identify factors associated with macrolide resistance. Study participants were identified through population-based surveillance in a 5-county region surrounding Philadelphia. Forty-three hospitals contributed 444 patients, who were interviewed by telephone regarding potential risk factors. In multivariable analyses, prior exposure to a macrolide antimicrobial agent (odds ratio [OR] 2.8), prior flu vaccination (OR 2.0), and Hispanic ethnicity (OR 4.1) were independently associated with an increased probability of macrolide resistance, and a history of stroke was independently associated with a decreased probability of macrolide resistance (OR 0.2). Fifty-five percent of patients with macrolide-resistant infections reported no antimicrobial drug exposure in the preceding 6 months. Among patients who reported taking antimicrobial agents in the 6 months preceding infection, failure to complete the course of prescribed drugs was associated with an increased probability of macrolide resistance (OR 3.4).

PubMed Disclaimer

Figures

Figure
Figure
MIC distribution of resistant isolates. This figure displays the proportion of resistant isolates at each MIC. Isolates with clindamycin susceptibility are analyzed separately from isolates with clindamycin resistance. The total number of isolates is 76.
See this image and copyright information in PMC

References

    1. Plouffe JF, Breiman RF, Facklam RR. Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group. JAMA. 1996;275:194–8. 10.1001/jama.275.3.194 - DOI - PubMed
    1. Metlay JP. Antibacterial drug resistance: implications for the treatment of patients with community-acquired pneumonia. Infect Dis Clin North Am. 2004;18:777–90. 10.1016/j.idc.2004.07.003 - DOI - PubMed
    1. Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med. 2000;343:1917–24. 10.1056/NEJM200012283432603 - DOI - PubMed
    1. Karlowsky JA, Thornsberry C, Jones ME, Evangelista AT, Critchley IA, Sahm DF. Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998–2002). Clin Infect Dis. 2003;36:963–70. 10.1086/374052 - DOI - PubMed
    1. MacDougall C, Guglielmo BJ, Maselli J, Gonzales R. Antimicrobial drug prescribing for pneumonia in ambulatory care. Emerg Infect Dis. 2005;11:380–4. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources